Tommy G. Thompson, Director at TherapeuticsMD, Inc. (TXMD), bought 5,000 shares at $1.06 ($5K) on 2021-05-14, disclosed to the SEC on 2021-05-18.
Open-market purchase of $5k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TXMD | BUY | 2025-12-29 | $14K | — | Filing → |
| UTHR | SELL | 2025-12-19 | $911K | — | Filing → |
| UTHR | SELL | 2025-09-10 | $3.7M | — | Filing → |